News

Which paclitaxel schedule works best for breast cancer?


 

AT THE ASCO ANNUAL MEETING 2013

CHICAGO – Dr. G. T. Budd, of the Cleveland Clinic, discusses the efficacy, side effects, and costs of giving paclitaxel weekly vs. every 2 weeks when treating breast cancer. Dr. Budd discussed trial results comparing the schedules in an interview at the annual meeting of the American Society of Clinical Oncology.

Recommended Reading

Online cancer community colaunched by ex-Google executive
Breast Cancer ICYMI
Genetic tests gauge breast-cancer recurrence risk
Breast Cancer ICYMI
Cancer-cell reprogramming poses new treatment challenge
Breast Cancer ICYMI
Intratumor heterogeneity drives need for multiple biopsies
Breast Cancer ICYMI
New imaging promises improved breast cancer utility
Breast Cancer ICYMI
Resistance exercise interventions during and following cancer treatment: a systematic review
Breast Cancer ICYMI
Utilization of radiotherapy services by a palliative care unit: pattern and implication
Breast Cancer ICYMI
ASCO guidelines for fertility preservation affirm oocyte preservation
Breast Cancer ICYMI
10 years of tamoxifen halves risk of death from breast cancer
Breast Cancer ICYMI
How I screen patients at increased risk for breast cancer
Breast Cancer ICYMI